Aerie Pharmaceuticals Inc

Bank of New York Mellon Corp

Report date

9/30/2022

Quarter

2022 Q3

Filed

11/14/2022

Shares

238,464

Value ($000)

3,608

Weight

0.0%

2013 Q4 - 2022 Q3 (14 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2022 Q3	11/14/2022	3,608	0.0%	238,464	9/30/2022
2022 Q2	8/15/2022	1,711	0.0%	228,059	6/30/2022
2022 Q1	5/11/2022	2,015	0.0%	221,411	3/31/2022
2021 Q4	2/11/2022	1,403	0.0%	199,654	12/31/2021
2021 Q3	11/18/2021	2,279	0.0%	199,991	9/30/2021
2021 Q2	8/11/2021	3,029	0.0%	189,198	6/30/2021
2021 Q1	5/13/2021	3,822	0.0%	213,846	3/31/2021
2020 Q4	2/9/2021	2,934	0.0%	217,160	12/31/2020
2020 Q3	11/12/2020	15,010	0.0%	1,275,272	9/30/2020
2020 Q2	8/12/2020	18,965	0.0%	1,284,820	6/30/2020
2020 Q1	5/6/2020	18,237	0.0%	1,350,758	3/31/2020
2019 Q4	2/14/2020	33,541	0.0%	1,387,682	12/31/2019
2014 Q1	5/14/2014	697	0.0%	32,911	3/31/2014
2013 Q4	2/12/2014	425	0.0%	23,650	12/31/2013